Overexpression of TFF3 is Associated with Immune Infiltration, Molecular Subtypes, and Clinical Progression in Breast Cancer
TFF3 is a robust diagnostic biomarker for BRCA molecular subtyping, an independent prognostic factor, and a potential immunomodulator. These findings highlight its clinical utility for patient stratification and potential as a therapeutic target, particularly in hormone receptor-positive BRCA.
Authors
- Han-Han Liu
- R. Stephanie Huang (ORCID: https://orcid.org/0000-0002-9862-0368)
- Ziming Huang
- Junbo Hu (ORCID: https://orcid.org/0009-0008-6942-6612)
- Qin Wang
- Hui Xu
- Xiao-hong Min
- Huan Wu
- Bei Liu
- Yong-qing Tong
Institutions
- Fujian Medical University (CN)
- Hubei Provincial Women and Children's Hospital (CN)
- Second Affiliated Hospital of Fujian Medical University (CN)
Publication Details
- Journal
- Current Medical Science
- Published
- 2026-03-04
- DOI
- https://doi.org/10.1007/s11596-026-00173-0
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00